
Targeting the Extracellular Matrix With Tenascin-C-Specific CAR T Cells Extends Survival in Preclinical Models of Glioblastoma
<a href="https://news.google.com/rss/articles/CBMi8wFBVV95cUxNaXVNblpOQ2Zabzdkc1ctTU1QSUFLb0tkb3pGU2ZJZzZKeTBucEVlaXVoY2taR1pDRTNhZFlJQlNVZXJyNXZKX2swQVJPSldOZ1ZUTGdoc0hLbmtvcVNKVHhtTTdWWVYyNFl0RUNPcDVVZC1EUHItOFF6TVVPejhlRHVYckFaSnlGalVZQURIT1JWVVJPTFkyOU8yVG9qMVU1ZWVhVGxqRGpmb1h4bkMxSzNXTWd3S2FLSC1HODBqZ3BMcnFQdFQ3U194cTk0MldlcTJxTFZzLUdzZ0RMRUdJMEF4dDBwT095RVFFVl9mSWRFLU0?oc=5" target="_blank">Targeting the Extracellular Matrix With Tenascin-C-Specific CAR T Cells Extends Survival in Preclinical Models of Glioblastoma</a>&nbsp;&nbsp;<font color="#6f6f6f">CancerNetwork</font>

